drugset / Trial / NCT03386448
The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major Depression
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this clinical trial is to determine the safety and efficacy of scopolamine utilized in conjunction with naltrexone for the treatment of major depression.
Timeline
- Start
- 2018-01-01
- Primary completion
- 2018-11-20
- Completion
- 2018-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | — | Other |
| Subject | Scopolamine | Unknown | — | Other |